RGT.AX · ARGENT BIOPHARMA LIMITED
Australia · RS rating 8 · As of 2026-10-14
| Price | 0.03 AUD |
|---|---|
| 1-day change | -7.1% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 19 / 3 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 17 / 6 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +70.8% |
| Market cap (USD) | $2.5M |